✦ LIBER ✦

Neoadjuvant chemotherapy paclitaxel + doxorubicin (PD) vs fluorouracil + doxorubicin + cyclophosphamide (FAC) in locally advanced breast cancer: Clinical and pathological response

✍ Scribed by V.F. Semiglazov; A.A. Bojok; A.S. Arsumanov; O.A. Ivanova; V.G. Ivanov; V.V. Semiglazov; K.M. Pozharissky; E.E. Topuzov; K.S. Nurgaziev; R.M. Paltuev

Book ID: 117658463
Publisher: Elsevier Science
Year: 2001
Tongue: English
Weight: 318 KB
Volume: 37
Category: Article
ISSN: 0959-8049
DOI: 10.1016/s0959-8049(01)81098-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Neoadjuvant chemotherapy with cyclophosp

Neoadjuvant chemotherapy with cyclophosphamide, doxorubicin and 5-fluorouracil (CAF) or cyclophosphamide, methotrexate and 5-fluorouracil (CMF) in 69 cases of locally advanced (stage IIIb) breast cancer

✍ Pankaj Gupta; Loveleen Bilani; Gaur K. Rath; Anoop Misra; Mahesh C. Mishra; Nuta 📂 Article 📅 1991 🏛 Springer 🌐 English ⚖ 340 KB

P88 Neoadjuvant chemotherapy with infusi

P88 Neoadjuvant chemotherapy with infusional 5-Fluorouracil, Doxorubicin and cyclophosphamide in locally advanced breast cancer and c-erb-B2 as a prognostic indicator

✍ H. Jeung; S. Rha; Y. Moon; Y. Choi; W. Yang; C. Suh; J. Roh; G. Kim; H. Chung 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 154 KB

Pharmacogenomic Predictor of Sensitivity

Pharmacogenomic Predictor of Sensitivity to Preoperative Chemotherapy With Paclitaxel and Fluorouracil, Doxorubicin, and Cyclophosphamide in Breast Cancer

✍ Hess, K. R.; Anderson, K.; Symmans, W. F.; Valero, V.; Ibrahim, N.; Mejia, J. A. 📂 Article 📅 2006 🏛 American Society of Clinical Oncology 🌐 English ⚖ 362 KB

A phase III trial of taxotere and doxoru

A phase III trial of taxotere and doxorubicin (AT) versus 5-fluorouracil, doxorubicin and cyclophosphamide (FAC) in patients with unresectable locally advanced breast cancer: an interim analysis

✍ K. Bouzid; J. Vinholes; F. Salas; E. Mickiewicz; S. Valdivia; V. Ostapenko; E. B 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 182 KB

Clinical and pathological predictors of

Clinical and pathological predictors of the response to neoadjuvant anthracycline chemotherapy in locally advanced breast cancer

✍ Mónica Fernández-Sánchez; Armando Gamboa-Dominguez; Norma Uribe; Ana Cristina Ga 📂 Article 📅 2006 🏛 Springer US 🌐 English ⚖ 93 KB

Prospective randomized trial of 5-fluoro

Prospective randomized trial of 5-fluorouracil, doxorubicin, and cyclophosphamide (FAC) versus paclitaxel and FAC (TFAC) in patients with operable breast cancer: impact of taxane chemotherapy on locoregional control

✍ Jeffrey M. Albert; Aman U. Buzdar; Reina Guzman; Pamela K. Allen; Eric A. Strom; 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 240 KB